SELECTION OF BEHAVIOURAL AND BIOCHEMICAL ENDPOINTS FOR THE PLANNED STUDY OF ISOQUINOLINE–QUINOLINE HYBRID COMPOUNDS
K.K. Akhmadjonov¹¹Tashkent Pharmaceutical Institute, Tashkent, Uzbekistan,Azizbek Azamatov²S.Yu. Yunusov Institute of the Chemistry of Plant Substances, Academy of Sciences of the Republic of Uzbekistan, Tashkent, UzbekistanU.A. Kurbonov²²S.Yu. Yunusov Institute of the Chemistry of Plant Substances, Academy of Sciences of the Republic of Uzbekistan, Tashkent, UzbekistanSherzod Zhurakulov²S.Yu. Yunusov Institute of the Chemistry of Plant Substances, Academy of Sciences of the Republic of Uzbekistan, Tashkent, UzbekistanWorldly Knowledge Publishing Centre
2026
ABI
Annotatsiya
The sensitivity of a preclinical study is determined not only by the choice of the model of parkinsonian syndrome but also by which measures are recorded and how they are analysed statistically. Experience shows that a considerable proportion of methodologically vulnerable conclusions arise not from the conduct of the experiment but from an inadequate choice of endpoint: the use of a test insensitive to the type of deficit in question, the recording of a measure at a single time point, or the analysis of ordinal variables by parametric methods.
Hali tarjima qilinmagan
Identifikatorlar
Iqtiboslar va manbalar
0 ta iqtibos0 ta foydalanilgan manba